Tobira Therapeutics (TBRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -49,617 | -24,100 | -18,589 | -13,062 | -19,198 |
| Depreciation Amortization | 18,419 | 2,075 | 2,095 | 477 | 485 |
| Income taxes - deferred | -4,393 | 0 | 0 | N/A | N/A |
| Accounts payable and accrued liabilities | 2,523 | 2,852 | -2,373 | -117 | -1,559 |
| Other Working Capital | 2,915 | 1,432 | -1,973 | -2,306 | -4,041 |
| Other Operating Activity | -1,141 | -924 | 3,946 | 779 | 2,571 |
| Operating Cash Flow | $-31,294 | $-18,665 | $-16,894 | $-14,229 | $-21,742 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -39 | -180 | -1 | -17 | -18 |
| Net Acquisitions | 33,232 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | -340 | -217 |
| Other Investing Activity | 0 | 0 | 0 | -340 | -171 |
| Investing Cash Flow | $33,193 | $-180 | $-1 | $-357 | $-189 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 12,954 | 22,776 | 11,980 | 6,781 | N/A |
| Debt Repayment | -21 | -1,841 | -2,000 | -1,500 | 6,000 |
| Common Stock Issued | 41,421 | 0 | 63 | 0 | 16 |
| Other Financing Activity | 0 | 0 | 0 | 14,834 | 11,470 |
| Financing Cash Flow | $54,354 | $20,935 | $10,043 | $20,115 | $17,486 |
| Beginning Cash Position | 6,178 | 4,088 | 10,940 | 9,235 | 13,680 |
| End Cash Position | 62,431 | 6,178 | 4,088 | 14,764 | 9,235 |
| Net Cash Flow | $56,253 | $2,090 | $-6,852 | $5,529 | $-4,445 |
| Free Cash Flow | |||||
| Operating Cash Flow | -31,294 | -18,665 | -16,894 | -14,229 | -21,742 |
| Capital Expenditure | -39 | -180 | -1 | -17 | -18 |
| Free Cash Flow | -31,333 | -18,845 | -16,895 | -14,246 | -21,760 |